NCT04833361

Brief Summary

Background: Uveal coloboma is a congenital eye malformation. It is thought to be a genetic condition. But it might have environmental causes as well. Researchers want to study the mothers of children with coloboma. They will use parts of the National Birth Defects Prevention Study (NBDPS) Mother Questionnaire. NBDPS was a large study of birth defects. It collected data from 1997 to 2011. Researchers will use NBDPS and NIH data as well as the new survey to produce data that can serve as a basis for further study. Objective: To explore maternal factors and exposures during the first trimester of pregnancy as potential causes of uveal coloboma and to correlate exposure data to clinical data from affected children. Eligibility: Mothers of probands with coloboma who have taken part in NIH study 06-EI-0230, 04-EI-0039, or 13-EI-0049. Design: This is a hybrid study. It will use existing data from NBDPS and NIH studies. It will also use NBDPS for a new survey of mothers of children with coloboma. Participants will take the survey by phone. Their pregnancy records may be reviewed. They will be asked about: Important dates Health and medicines Tobacco, alcohol, and substance use Parents occupations Family demographics. The survey will take 1 hour or less to complete. Some data were obtained in past NIH studies. These data are largely from children. Some family data may be used as well. For example, eye exam data, gene test results, and family history of coloboma may be used. If a participant did not consent to the future use of their data, then their data will not be used. Data will be stored in a secure NIH database. ...

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 6, 2021

Completed
2.2 years until next milestone

Study Start

First participant enrolled

June 20, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 17, 2025

Completed
Last Updated

October 2, 2025

Status Verified

September 30, 2025

Enrollment Period

1.7 years

First QC Date

April 5, 2021

Last Update Submit

October 1, 2025

Conditions

Keywords

QuestionnaireMicrophthalmiaBirth DefectsNatural History

Outcome Measures

Primary Outcomes (1)

  • % of participants with x exposure compared to historical data

    % of participants with x exposure compared to historical data from NBDPS study.

    ongoing

Study Arms (1)

Mothers

Mothers of children with coloboma.

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Up to 180 mothers of probands with coloboma that have previously been consented to an NIH protocol studying coloboma.

You may qualify if:

  • mothers of probands with coloboma that have previously been consented to an NIH protocol studying coloboma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Eye Institute (NEI)

Bethesda, Maryland, 20892, United States

Location

MeSH Terms

Conditions

ColobomaMicrophthalmosCongenital Abnormalities

Condition Hierarchy (Ancestors)

Eye AbnormalitiesEye DiseasesEye Diseases, HereditaryCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Brian P Brooks, M.D.

    National Eye Institute (NEI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
OTHER
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2021

First Posted

April 6, 2021

Study Start

June 20, 2023

Primary Completion

March 17, 2025

Study Completion

March 17, 2025

Last Updated

October 2, 2025

Record last verified: 2025-09-30

Locations